Key Insights

Highlights

Treatment Research

1 treatments under study, led by Hospitalization

Research Leaders

5 sponsors active, led by University Hospital, Basel, Switzerland

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Hospitalization1

Active Sponsors

  • University Hospital, Basel, Switzerland1
  • Insel Gruppe AG, University Hospital Bern1
  • University of Lausanne Hospitals1
  • University Hospital, Zürich1
  • University Hospital, Geneva1

Top Investigators

Related Conditions

  • Quality Of Care1
  • Prom1
  • Internal Medicine1

Activity Timeline